🇺🇸 Revolade® in United States

Revolade® (Revolade®) regulatory status in United States.

Marketing authorisation

FDA

  • Application: ANDA208815
  • Marketing authorisation holder: ACTAVIS LABS FL INC
  • Local brand name: ELTROMBOPAG
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Revolade® in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in United States

Frequently asked questions

Is Revolade® approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Revolade® in United States?

ACTAVIS LABS FL INC holds the US marketing authorisation.